INS and metabolic disease: Third, designing combination therapeutic regimens that pair peripheral interventions, like insulin sensitizers for metabolic disorders, with central anti-inflammatory agents, a strategy aimed at breaking the self-perpetuating “brain–periphery” vicious cycles underlying many chronic diseases.